Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

Alpha Tau to Participate in May Investor Conferences

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

Alpha Tau Medical CFO Raphi Levy: "42nd Annual JP Morgan Healthcare Conference 2024: Watch out for the radiotherapy market"

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Alpha Tau to Participate in Sidoti Small-Cap Conference

Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results

ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer